News - GlaxoSmithKline, Vaccines

Filter

Current filters:

GlaxoSmithKlineVaccines

Popular Filters

1 to 25 of 50 results

GSK commits to five-year vaccine price freeze for countries graduating from GAVI Alliance support

22-05-2014

UK pharma giant GlaxoSmithKline has said it will freeze the prices of its vaccines for a period of five…

GlaxoSmithKlineGlobalPharmaceuticalPricingVaccines

Novartis swaps products with GlaxoSmithKline, sells unit to Lilly

Novartis swaps products with GlaxoSmithKline, sells unit to Lilly

22-04-2014

In what looks like a significant restructuring of company focuses, Swiss drug major Novartis and UK peer…

Eli LillyGlaxoSmithKlineMergers & AcquisitionsNovartisPharmaceuticalVaccines

Cost is preventing boys receiving anti-cancer vaccine for HPV

Cost is preventing boys receiving anti-cancer vaccine for HPV

13-02-2014

While national health systems have been pushing to increase the human papillomavirus (HPV) vaccine uptake…

CervarixEuropeGardasilGlaxoSmithKlineHealthcareMerck & CoPharmaceuticalUSAVaccines

CHMP positive opinion for GSK’s Cervarix two-dose schedule

CHMP positive opinion for GSK’s Cervarix two-dose schedule

28-11-2013

UK pharma giant GlaxoSmithKline says that the European Medicines Agency's Committee for Medicinal Products…

CervarixEuropeGlaxoSmithKlineOncologyPharmaceuticalRegulationVaccines

US FDA clears GlaxoSmithKline’s H5N1 flu vaccine

26-11-2013

The US Food and Drug Administration has approved UK pharma giant GlaxoSmithKline’s pandemic Influenza…

GlaxoSmithKlineNorth AmericaPharmaceuticalRegulationVaccines

Merck’s new HPV vaccine could rejuvenate market, says GlobalData

Merck’s new HPV vaccine could rejuvenate market, says GlobalData

18-11-2013

Despite being hampered both by apathy and resistance in recent years, the human papillomavirus (HPV)…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalV503VaccinesWomen's Health

Uptake of HPV vaccines must increase to reap rewards

Uptake of HPV vaccines must increase to reap rewards

08-11-2013

Here's our take on the week's top stories.

CervarixGlaxoSmithKlineHealthcareMerck & CoOncologyPharmaceuticalVaccines

New data support GSK’s Cervarix two-dose schedule

New data support GSK’s Cervarix two-dose schedule

04-11-2013

UK pharma giant GlaxoSmithKline has revealed the results of a Phase III study of its HPV vaccine, Cervarix,…

CervarixGlaxoSmithKlineOncologyPharmaceuticalResearchVaccines

Agreements for influenza vaccine approved in New Zealand

15-10-2013

New Zealand’s PHARMAC has reached agreements with subsidiaries of GlaxoSmithKline and Abbott Laboratories…

Abbott LaboratoriesFluarixGlaxoSmithKlineHealthcareInfluvacNew ZealandPharmaceuticalPricingVaccines

New data support GSK plan to file for approval of malaria vaccine in 2014

New data support GSK plan to file for approval of malaria vaccine in 2014

08-10-2013

Results from a large-scale Phase III trial, presented today at the Multilateral Initiative on Malaria…

GlaxoSmithKlinePharmaceuticalRegulationResearchRTS,STropical diseasesVaccines

US NIH trials flu vaccines from Sanofi and Novartis

US NIH trials flu vaccines from Sanofi and Novartis

19-09-2013

The US National Institutes of Health has begun testing an H7N9 avian influenza vaccine candidate in humans.

GlaxoSmithKlineHealthcareNorth AmericaNovartisPharmaceuticalSanofi PasteurVaccines

GlaxoSmithKline's cancer drug candidate fails endpoint in melanoma

05-09-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and partner US biotech firm Agenus (Nasdaq: AGEN) this morning…

AgenusBiotechnologyGlaxoSmithKlineMAGE-A3OncologyPharmaceuticalResearchVaccines

New Zealand proposals for influenza vaccines

21-08-2013

New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to list two…

Abbott LaboratoriesAsia-PacificFluarixGlaxoSmithKlineInfluvacPharmaceuticalPricingRegulationVaccines

GSK's Flulaval vaccine approved by US FDA

16-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has had its Flulaval quadrivalent intramuscular influenza…

FluarixFlulavalGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationVaccines

US FDA approves shipment of quadrivalent flu vaccine to health care providers

06-08-2013

The US subsidiary of UK pharma giant GlaxoSmithKline (LSE: GSK) says it has received Food and Drug Administration…

Anti-viralsFluarixGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationVaccines

GAVI Alliance gets reduced price offers from Pfizer and GSK

30-07-2013

The price that the GAVI Alliance, a public/private partnership, pays for lifesaving pneumococcal vaccines…

GlaxoSmithKlineGlobalPfizerPharmaceuticalPricingVaccines

Slow uptake of HPV vaccine in USA "risks health of next generation"

29-07-2013

US human papillomavirus (HPV) vaccination rates in girls aged 13-17 years failed to increase between…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoNorth AmericaPharmaceuticalVaccines

Japan vaccines briefs: Gardasil and Cervarix; Daiichi Sankyo files NDA

21-06-2013

The Japanese Ministry of Health, Labor and Welfare has decided to withdraw its recommendation for a vaccination…

Asia-PacificCervarixDaiichi SankyoGardasilGlaxoSmithKlineMerck & CoPharmaceuticalRegulationVaccinesWomen's Health

GSK to boost vaccines business with 250 million-euro buy of Swiss firm Okairos

30-05-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday (May 29) revealed that it has acquired Swiss closely-held…

BiotechnologyGlaxoSmithKlineMergers & AcquisitionsOkairosPharmaceuticalVaccines

Adult vaccines market controlled by GSK and Merck

15-04-2013

The adult vaccines market has been forecast to increase at a compound annual growth rate (CAGR) of 5.6%…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPfizerPharmaceuticalPrevnarVaccines

GlaxoSmithKline cleared for $91M flu vaccine plant in USA; Gets CRL on Q-Plan H5N1

27-03-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and The Texas A&M University System (TAMUS) say that the US…

GlaxoSmithKlineNorth AmericaPharmaceuticalProductionQ-Plan H5N1RegulationVaccines

GlaxoSmithKline and Abbott to start production in Ukraine

19-03-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and the USA's Abbott (NYSE: ABT) are considering launching…

Anti-viralsAntibiotics and Infectious diseasesEuropeGlaxoSmithKlineIndarPharmaceuticalProductionVaccines

GAVI Alliance funds vaccines for cervical cancer in developing countries

08-02-2013

More than 180,000 girls in eight developing countries are set to receive protection against the leading…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoPharmaceuticalRest of the WorldVaccinesWomen's Health

GlaxoSmithKline and Biological E set up JV to develop combination vaccine

29-01-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and Indian vaccines company Biological E have entered into…

Asia-PacificBiological E LtdGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalResearchVaccines

1 to 25 of 50 results

Back to top